Verition Fund Management
DXCM icon

Verition Fund Management’s DexCom DXCM Stock Holding History

Verition Fund Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$754K Buy
12,000
+6,100
+103% +$425K ﹤0.01% 1426
2025
Q4 		$392K Sell
5,900
-85,900
-94% -$5.55M ﹤0.01% 2842
2025
Q3 		$6.18M Buy
91,800
+8,500
+10% +$673K 0.03% 927
2025
Q2 		$7.27M Buy
83,300
+36,800
+79% +$2.88M 0.03% 741
2025
Q1 		$3.18M Buy
+46,500
New +$3.79M 0.01% 1231
2024
Q3 		– Sell
-28,100
Closed -$3.19M – 3264
2024
Q2 		$3.19M Buy
28,100
+13,500
+92% +$1.71M 0.02% 1000
2024
Q1 		$2.03M Buy
14,600
+12,900
+759% +$1.62M 0.01% 1201
2023
Q4 		$211K Buy
+1,700
New +$174K ﹤0.01% 2009
2023
Q3 		– Sell
-1,700
Closed -$218K – 2429
2023
Q2 		$218K Buy
+1,700
New +$206K ﹤0.01% 1781
2022
Q2 		– Sell
-42,800
Closed -$5.47M – 2532
2022
Q1 		$5.47M Hold
42,800
– – 0.07% 347
2021
Q4 		$5.75M Buy
42,800
+26,800
+168% +$3.85M 0.04% 306
2021
Q3 		$2.19M Buy
+16,000
New +$2.02M 0.02% 587

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Verition Fund Management's DXCM Position: Q1 2026 in Review

Verition Fund Management increased its DexCom (DXCM) stake by 32% in Q1 2026, buying an estimated $1.27M and bringing the position to 75,460 shares worth $4.74M. The position accounts for 0.03% of the portfolio, ranked #607.

Verition Fund Management first reported a position in DXCM in Q3 2014 and has held it in 31 quarters since. The position peaked at $9.02M in Q3 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Verition Fund Management held 75,460 shares of DexCom worth $4.74M as of Q1 2026.
  • Verition Fund Management bought 18,188 DexCom shares in Q1 2026, an estimated $1.27M.
  • DexCom made up 0.03% of Verition Fund Management's portfolio in Q1 2026, its #607 holding.
  • Verition Fund Management first reported a position in DexCom in Q3 2014 and has held it in 31 quarters since.
  • Verition Fund Management's DexCom position peaked at $9.02M in Q3 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.